Odyssey Therapeutics (ODTX) Stock Looks Reasonable As AI Research News LandsSimplywall·Aug 9 at 02:30 PMODTX+10.48%EVO+3.66%
Odyssey Therapeutics (NASDAQ:ODTX) Given New $29.00 Price Target at JPMorgan Chase & Co.Market Beat·Aug 7 at 11:42 AMODTX+10.48%
Evotec and Odyssey collaborate on AI-enabled R&DPharmaceutical Technology·Aug 7 at 04:10 AMODTX+10.48%EVO+3.66%
Biotech Stocks At 52-Week Highs - BVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRSrttnews·Aug 6 at 03:55 AMACRS+2.14%CRL+3.87%
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases | EVO Stock NewsStockTitan·Aug 5 at 05:16 PMODTX+10.48%EVO+3.66%
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateUnusual Whales·Aug 4 at 06:02 AMODTX+10.48%
Odyssey posts June 2026 corporate presentation highlighting OD-001 Phase 2a results and $464M pro forma cashTradingView·Jun 23 at 07:53 AMODTX+10.48%
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate UpdateUnusual Whales·Jun 19 at 04:23 PMODTX+10.48%
